ENSG
The Ensign Group, Inc. [ENSG] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ENSG Stock Summary
Top 10 Correlated ETFs
ENSG
Top 10 Correlated Stocks
ENSG
In the News
ENSG Financial details
Company Rating
Strong Buy
Market Cap
6.76B
Income
209.4M
Revenue
3.73B
Book val./share
26.6
Cash/share
9.39
Dividend
0.23
Dividend %
0.2%
Employees
35.3K
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
25.71
Forward P/E
-
PEG
-31.86
P/S
1.81
P/B
4.37
P/C
12.34
P/FCF
27.29
Quick Ratio
1.42
Current Ratio
1.48
Debt / Equity
1.25
LT Debt / Equity
1.19
-
-
EPS (TTM)
3.76
EPS next Y
-
EPS next Q
-
EPS this Y
-8.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.68%
Revenue last 5Y
12.86%
Revenue Q/Q
4.21%
EPS Q/Q
-65.79%
-
-
-
-
SMA20
-4.07%
SMA50
0.85%
SMA100
9.26%
Inst Own
84.18%
Inst Trans
0.89%
ROA
6%
ROE
18%
ROC
0.09%
Gross Margin
16%
Oper. Margin
9%
Profit Margin
7%
Payout
5%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
87.14-127.58
52W High
-8.73%
52W Low
+33.23%
RSI
37
Rel Volume
0.39
Avg Volume
270.09K
Volume
105.81K
Perf Week
-1.28%
Perf Month
-6.76%
Perf Quarter
21.56%
Perf Half Y
20.41%
-
-
-
-
Beta
0.943
-
-
Volatility
1.27%, 2.65%
Prev Close
-1.62%
Price
115.91
Change
-1.86%
ENSG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 38.1 | 44.96 | 48.22 | 55.12 | 66.94 | |
| Net income per share | 2.07 | 3.19 | 3.57 | 4.09 | 3.76 | |
| Operating cash flow per share | 3.16 | 6.99 | 5.06 | 4.96 | 6.76 | |
| Free cash flow per share | 1.82 | 6.05 | 3.78 | 3.37 | 4.86 | |
| Cash per share | 1.44 | 4.68 | 5.06 | 6.04 | 9.46 | |
| Book value per share | 12.28 | 15.31 | 18.75 | 22.75 | 26.78 | |
| Tangible book value per share | 11.14 | 14.17 | 17.52 | 21.23 | 25.38 | |
| Share holders equity per share | 12.28 | 15.31 | 18.75 | 22.75 | 26.78 | |
| Interest debt per share | 25.49 | 21.02 | 23.35 | 28.84 | 33.74 | |
| Market cap | 2.43B | 3.9B | 4.57B | 5.19B | 6.25B | |
| Enterprise value | 3.71B | 4.77B | 5.58B | 6.45B | 7.61B | |
| P/E ratio | 21.94 | 22.86 | 23.5 | 23.11 | 29.85 | |
| Price to sales ratio | 1.19 | 1.62 | 1.74 | 1.72 | 1.68 | |
| POCF ratio | 14.36 | 10.44 | 16.59 | 19.06 | 16.6 | |
| PFCF ratio | 24.9 | 12.06 | 22.19 | 28.07 | 23.11 | |
| P/B Ratio | 3.7 | 4.76 | 4.48 | 4.16 | 4.19 | |
| PTB ratio | 3.7 | 4.76 | 4.48 | 4.16 | 4.19 | |
| EV to sales | 1.82 | 1.99 | 2.12 | 2.13 | 2.04 | |
| Enterprise value over EBITDA | 20.3 | 16.96 | 17.39 | 17.9 | 21.55 | |
| EV to operating cash flow | 21.98 | 12.79 | 20.23 | 23.67 | 20.21 | |
| EV to free cash flow | 38.12 | 14.78 | 27.06 | 34.87 | 28.14 | |
| Earnings yield | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | |
| Free cash flow yield | 0.04 | 0.08 | 0.05 | 0.04 | 0.04 | |
| Debt to equity | 2.05 | 1.36 | 1.24 | 1.26 | 1.25 | |
| Debt to assets | 0.57 | 0.44 | 0.44 | 0.46 | 0.45 | |
| Net debt to EBITDA | 7.04 | 3.12 | 3.13 | 3.49 | 3.85 | |
| Current ratio | 1.2 | 1.04 | 1.22 | 1.34 | 1.42 | |
| Interest coverage | 8.25 | 23.84 | 38.03 | 33.24 | 31.58 | |
| Income quality | 1.51 | 2.18 | 1.39 | 1.21 | 1.79 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.09 | 0.06 | 0.06 | 0.05 | 0.06 | |
| Sales general and administrative to revenue | 0.05 | 0.05 | 0.06 | 0.05 | 0.07 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.42 | -0.13 | -0.25 | -0.32 | -0.28 | |
| Capex to revenue | -0.04 | -0.02 | -0.03 | -0.03 | -0.03 | |
| Capex to depreciation | -1.4 | -0.92 | -1.24 | -1.4 | -1.47 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 23.9 | 33.15 | 38.82 | 45.78 | 47.59 | |
| ROIC | 0.03 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Return on tangible assets | 0.05 | 0.07 | 0.07 | 0.07 | 0.05 | |
| Graham Net | -26.3 | -23.49 | -471.27 | -28.47 | -32.12 | |
| Working capital | 67.91M | 20.56M | 116.64M | 199.05M | 312.18M | |
| Tangible asset value | 595.23M | 757.14M | 954.87M | 1.17B | 1.41B | |
| Net current asset value | -1.29B | -1.14B | -1.19B | -1.42B | -1.63B | |
| Invested capital | 2.05 | 1.36 | 1.24 | 1.26 | 1.25 | |
| Average receivables | 292.54M | 307.02M | 316.9M | 368.58M | 446.74M | |
| Average payables | 44.6M | 47.94M | 54.51M | 67.6M | 84.95M | |
| Average inventory | -8.88M | -15.6M | -24.38B | -24.37B | 2.32M | |
| Days sales outstanding | 55.38 | 46.34 | 45.67 | 49.27 | 47.47 | |
| Days payables outstanding | 9.4 | 9.31 | 9.82 | 11.22 | 10.79 | |
| Days of inventory on hand | -3.71 | -2.46 | -8.24K | 0.68 | 0 | |
| Receivables turnover | 6.59 | 7.88 | 7.99 | 7.41 | 7.69 | |
| Payables turnover | 38.81 | 39.2 | 37.15 | 32.53 | 33.82 | |
| Inventory turnover | -98.31 | -148.35 | -0.04 | 540.06 | 0 | |
| ROE | 0.17 | 0.21 | 0.19 | 0.18 | 0.14 | |
| Capex per share | -1.34 | -0.94 | -1.28 | -1.6 | -1.91 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 14.54 | 16.04 | 16.57 | 16.85 | 17.48 | |
| Net income per share | 1.09 | 1.08 | 1.15 | 1.14 | 0.39 | |
| Operating cash flow per share | 0.9 | 0.87 | 2.15 | 2.21 | 1.52 | |
| Free cash flow per share | 0.4 | 0.39 | 1.7 | 1.75 | 1.01 | |
| Cash per share | 5.96 | 6.28 | 7.91 | 8.67 | 9.39 | |
| Book value per share | 22.44 | 23.87 | 24.96 | 26.15 | 26.6 | |
| Tangible book value per share | 20.94 | 22.36 | 23.56 | 24.76 | 25.21 | |
| Share holders equity per share | 22.44 | 23.87 | 24.96 | 26.15 | 26.6 | |
| Interest debt per share | 28.32 | 34.51 | 33.98 | 33.88 | 33.4 | |
| Market cap | 5.27B | 5.28B | 5.31B | 5.19B | 6.29B | |
| Enterprise value | 6.52B | 6.86B | 6.78B | 6.61B | 7.65B | |
| P/E ratio | 21.77 | 22.07 | 20.74 | 20.31 | 72.53 | |
| Price to sales ratio | 6.51 | 5.96 | 5.76 | 5.51 | 6.42 | |
| POCF ratio | 104.95 | 109.29 | 44.34 | 42.07 | 73.8 | |
| PFCF ratio | 235.45 | 243.55 | 56.01 | 53.17 | 111.48 | |
| P/B Ratio | 4.22 | 4 | 3.83 | 3.55 | 4.22 | |
| PTB ratio | 4.22 | 4 | 3.83 | 3.55 | 4.22 | |
| EV to sales | 8.06 | 7.74 | 7.35 | 7.03 | 7.81 | |
| Enterprise value over EBITDA | 67.68 | 70.37 | 67.31 | 64.47 | 145.75 | |
| EV to operating cash flow | 130.02 | 141.96 | 56.59 | 53.6 | 89.77 | |
| EV to free cash flow | 291.69 | 316.37 | 71.5 | 67.74 | 135.6 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Free cash flow yield | 0 | 0 | 0.02 | 0.02 | 0.01 | |
| Debt to equity | 1.26 | 1.44 | 1.36 | 1.29 | 1.25 | |
| Debt to assets | 0.46 | 0.49 | 0.48 | 0.46 | 0.45 | |
| Net debt to EBITDA | 13.05 | 16.2 | 14.58 | 13.87 | 25.93 | |
| Current ratio | 1.34 | 1.42 | 1.5 | 1.48 | 1.42 | |
| Interest coverage | 36.38 | 36.78 | 38.49 | 39.42 | 11.39 | |
| Income quality | 0.83 | 0.81 | 1.87 | 1.93 | 3.91 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.15 | |
| Sales general and administrative to revenue | 0.05 | 0.06 | 0.06 | 0.05 | 0.11 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | -0.55 | -0.55 | -0.21 | -0.21 | -0.34 | |
| Capex to revenue | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | |
| Capex to depreciation | -1.65 | -1.56 | -1.42 | -1.4 | -1.5 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Graham number | 23.42 | 24.11 | 25.42 | 25.94 | 15.21 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Graham Net | -28.08 | -33.68 | -32.09 | -31.85 | -31.91 | |
| Working capital | 199.05M | 245.22M | 308.65M | 322.55M | 312.18M | |
| Tangible asset value | 1.17B | 1.24B | 1.31B | 1.38B | 1.41B | |
| Net current asset value | -1.42B | -1.71B | -1.63B | -1.62B | -1.63B | |
| Invested capital | 1.26 | 1.44 | 1.36 | 1.29 | 1.25 | |
| Average receivables | 381.19M | 426.31M | 445.1M | 459.07M | 478.58M | |
| Average payables | 70.29M | 79.28M | 79.84M | 77.65M | 84.95M | |
| Average inventory | 2.32M | 2.32M | 0.5 | 0.5 | 0.5 | |
| Days sales outstanding | 45.41 | 45.08 | 43.57 | 45.17 | 44.53 | |
| Days payables outstanding | 10.28 | 9.87 | 9.11 | 8.77 | 10.04 | |
| Days of inventory on hand | 0.62 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.98 | 2 | 2.07 | 1.99 | 2.02 | |
| Payables turnover | 8.75 | 9.12 | 9.88 | 10.27 | 8.96 | |
| Inventory turnover | 145.31 | 742.96M | 0 | 791.43M | 0 | |
| ROE | 0.05 | 0.05 | 0.05 | 0.04 | 0.01 | |
| Capex per share | -0.5 | -0.48 | -0.45 | -0.46 | -0.51 |
ENSG Frequently Asked Questions
What is The Ensign Group, Inc. stock symbol ?
The Ensign Group, Inc. is a US stock , located in San juan capistrano of Ca and trading under the symbol ENSG
What is The Ensign Group, Inc. stock quote today ?
The Ensign Group, Inc. stock price is $115.91 today.
Is The Ensign Group, Inc. stock public?
Yes, The Ensign Group, Inc. is a publicly traded company.
Company Profile
- Volume Average 270.09K
- Market Capitalization 6.76B
- Employee 35.3K
- CEO Mr. Barry R. Port
- Headquarters San Juan Capistrano,CA,US
- IPO Date 2007-11-09
-
Website
https://ensigngroup.net 
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
